Abbott Laboratories (ABT) Current Taxes (2016 - 2025)
Abbott Laboratories (ABT) has disclosed Current Taxes for 17 consecutive years, with $569.0 million as the latest value for Q4 2025.
- Quarterly Current Taxes fell 4.21% to $569.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $569.0 million through Dec 2025, down 4.21% year-over-year, with the annual reading at $569.0 million for FY2025, 4.21% down from the prior year.
- Current Taxes hit $569.0 million in Q4 2025 for Abbott Laboratories, up from $469.0 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $713.0 million in Q3 2024 to a low of $242.0 million in Q2 2021.
- Historically, Current Taxes has averaged $421.1 million across 5 years, with a median of $379.0 million in 2021.
- Biggest five-year swings in Current Taxes: soared 214.53% in 2021 and later crashed 35.11% in 2025.
- Year by year, Current Taxes stood at $306.0 million in 2021, then grew by 12.09% to $343.0 million in 2022, then skyrocketed by 43.44% to $492.0 million in 2023, then rose by 20.73% to $594.0 million in 2024, then decreased by 4.21% to $569.0 million in 2025.
- Business Quant data shows Current Taxes for ABT at $569.0 million in Q4 2025, $469.0 million in Q3 2025, and $390.0 million in Q2 2025.